tiprankstipranks
Trending News
More News >
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market

Verrica Pharmaceuticals (VRCA) Income Statement

Compare
484 Followers

Verrica Pharmaceuticals Income Statement

Last quarter (Q4 2025), Verrica Pharmaceuticals's total revenue was $5.09M, an increase of 1380.23% from the same quarter last year. In Q4, Verrica Pharmaceuticals's net income was $-8.07M. See Verrica Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 35.58M$ 7.57M$ 5.12M$ 9.03M$ 12.00M
Gross Profit
$ 32.14M$ 4.83M$ 4.38M$ 8.31M$ 11.53M
Operating Expenses
$ 44.08M$ 70.75M$ 70.14M$ 29.60M$ 42.44M
Depreciation and Amortization
$ 781.00K$ 1.27M$ 836.00K$ 718.00K$ 472.00K
EBITDA
$ -11.16M$ -65.90M$ -62.20M$ -21.60M$ -30.31M
Operating Income
$ -11.94M$ -65.92M$ -65.76M$ -21.30M$ -30.91M
Other Income/Expenses
$ -5.95M$ -10.66M$ -1.24M$ -3.19M$ -4.17M
Pretax Income
$ -17.89M$ -76.58M$ -67.00M$ -24.49M$ -35.08M
Net Income
$ -17.89M$ -76.58M$ -67.00M$ -24.49M$ -35.08M
Per Share Metrics
Basic EPS
$ -1.68$ -14.78$ -14.78$ -7.17$ -12.97
Diluted EPS
$ -1.68$ -14.78$ -14.78$ -7.17$ -12.97
Weighted Average Shares Outstanding
10.65M 5.18M 4.53M 3.42M 2.70M
Weighted Average Shares Outstanding (Diluted)
10.65M 5.18M 4.53M 3.42M 2.70M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History